当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 现金流量表

华北制药

(600812)

  

流通市值:84.24亿  总市值:84.24亿
流通股本:17.16亿   总股本:17.16亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,806,040,642.148,457,099,229.236,428,345,117.964,061,086,464.16
收到的税费返还23,912,679.43101,533,405.5163,467,634.1940,982,019.51
收到其他与经营活动有关的现金443,304,305.29198,107,736.32151,143,426.41106,716,162.37
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,273,257,626.868,756,740,371.066,642,956,178.564,208,784,646.04
购买商品、接受劳务支付的现金860,478,728.153,983,622,144.353,031,631,1691,874,005,059.56
支付给职工以及为职工支付的现金334,888,599.441,355,844,488.56969,041,711.4634,971,402.27
支付的各项税费111,302,470.04608,464,179.9495,408,123.39341,650,674.98
支付其他与经营活动有关的现金399,505,050.361,784,542,903.131,553,150,147.231,093,172,408.86
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,706,174,847.997,732,473,715.946,049,231,151.023,943,799,545.67
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额567,082,778.871,024,266,655.12593,725,027.54264,985,100.37
二、投资活动产生的现金流量:
取得投资收益收到的现金-589,474.35589,474.35-
处置固定资产、无形资产和其他长期资产收回的现金净额-690,945.34690,945.34373,400
投资活动现金流入的平衡项目-000
投资活动现金流入小计-1,280,419.691,280,419.69373,400
购建固定资产、无形资产和其他长期资产支付的现金192,682,233.74623,035,146.08380,130,233.54257,476,251.86
投资支付的现金-260,000,00050,000,000-
投资活动现金流出的平衡项目0000
投资活动现金流出小计192,682,233.74883,035,146.08430,130,233.54257,476,251.86
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-192,682,233.74-881,754,726.39-428,849,813.85-257,102,851.86
三、筹资活动产生的现金流量:
吸收投资收到的现金-10,000,000--
取得借款收到的现金1,845,940,0009,828,409,198.637,300,939,198.634,660,482,326.51
收到其他与筹资活动有关的现金176,510,000945,440,000914,770,250842,770,250
筹资活动现金流入平衡项目0000
筹资活动现金流入小计2,022,450,00010,783,849,198.638,215,709,448.635,503,252,576.51
偿还债务支付的现金1,917,547,397.939,580,605,569.246,872,403,046.184,312,480,208.5
分配股利、利润或偿付利息支付的现金118,501,797.36516,223,445.6367,466,453.84279,227,312.94
支付其他与筹资活动有关的现金475,793,117.811,391,163,495.741,281,072,267.89978,699,874.84
筹资活动现金流出平衡项目0000
筹资活动现金流出小计2,511,842,313.111,487,992,510.588,520,941,767.915,570,407,396.28
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-489,392,313.1-704,143,311.95-305,232,319.28-67,154,819.77
四、汇率变动对现金及现金等价物的影响2,477,280.4312,067,905.59,176,198.467,511,289.22
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-112,514,487.54-549,563,477.72-131,180,907.13-51,761,282.04
加:期初现金及现金等价物余额505,004,576.561,054,568,054.281,054,568,054.281,054,568,054.28
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额392,490,089.02505,004,576.56923,387,147.151,002,806,772.24
补充资料:
净利润-49,387,877.22-42,803,558.02
资产减值准备-14,475,002.15-14,906,253.89
固定资产和投资性房地产折旧-633,502,537.12-268,971,367.56
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-633,502,537.12-268,971,367.56
无形资产摊销-105,510,960.21-47,798,059.51
长期待摊费用摊销-10,792,317.18-5,099,862.53
处置固定资产、无形资产和其他长期资产的损失--755,826.15--466,650.78
财务费用-501,895,716.87-260,986,014.69
投资损失--46,851,144.77--23,768,373.32
递延所得税--1,844,679.4--
其中:递延所得税资产减少--1,844,679.4--
存货的减少--87,109,782.32-5,854,552.31
经营性应收项目的减少-342,828,226.73--389,144,620.51
经营性应付项目的增加--637,266,983.95--56,714,961.22
现金的期末余额-505,004,576.56-1,002,806,772.24
减:现金的期初余额-1,054,568,054.28-1,054,568,054.28
公告日期2024-04-262024-03-302023-10-272023-08-19
审计意见(境内)标准无保留意见
TOP↑